Physician profile
Brian Michael Schenavar
NPI 1396191516
$33,789.51
in general payments reported to CMS, 2019-2025
13 companies · $9,232 in 2025
The $9,232 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $383 · 2021: $1,276 · 2022: $2,597 · 2023: $16K · 2024: $4,047 · 2025: $9,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $4,547 · Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,118.75 |
| Travel and Lodging | $4,546.85 |
| Food and Beverage | $868.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $25,460.51 | 2022-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Hybrid |
| Trilliant Surgical LLC. | $4,454.68 | 2023-2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Novastep INC. | $1,981.25 | 2025 | Nexis |
| Steelhead Surgical INC | $1,200.00 | 2021 | |
| Stryker Corporation | $336.20 | 2020-2021 | |
| Integra Lifesciences Corporation | $83.93 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Encore Medical, Lp | $64.48 | 2021 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Sioux Surgical INC | $52.34 | 2023-2025 | |
| Ortho Solutions INC | $40.25 | 2023 | |
| Anika Therapeutics, INC. | $26.00 | 2022 | |
| Averitas Pharma INC. | $16.61 | 2023 | Qutenza |
| Organogenesis INC. | $15.43 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Schenavar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.